TRBC1 immunohistochemistry distinguishes cutaneous T-cell lymphoma from inflammatory dermatitis: A retrospective analysis of 39 cases
- PMID: 38061444
- PMCID: PMC10960695
- DOI: 10.1016/j.jaad.2023.11.051
TRBC1 immunohistochemistry distinguishes cutaneous T-cell lymphoma from inflammatory dermatitis: A retrospective analysis of 39 cases
Keywords: CTCL; FFPE; TRBC1; cutaneous T-cell lymphoma; flow cytometry lymphoma; formalin-fixed paraffin-embedded; immunohistochemistry; lymphoproliferative disorders.
Conflict of interest statement
Conflicts of interest The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article.
Figures


References
-
- Wang HW, Raffeld M. Molecular assessments of clonality in lymphoid neoplasms. Semin Hematol. 2019;56(1):37–45. - PubMed
-
- Berg H, Otteson GE, Corley H, et al. Flow cytometric evaluation of TRBC1 expression in tissue specimens and body fluids is a novel and specific method for assessment of T-cell clonality and diagnosis of T-cell neoplasms. Cytometry B Clin Cytom. 2021;100(3):361–369. - PubMed
-
- Horna P, Shi M, Jevremovic D, et al. Utility of TRBC1 expression in the diagnosis of peripheral blood involvement by cutaneous t-cell lymphoma. J Invest Dermatol. 2021;141(4):821–829. - PubMed
-
- Maciocia PM, Wawrzyniecka PA, Philip B, et al. Targeting the T cell receptor B-chain constant region for immunotherapy of T cell malignancies. Nat Med. 2017;23(12):1416–1423. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical